Insights On Quality Control
-
Modernizing Compendial SEC Methods For Biotherapeutics
4/16/2024
Explore the advantages of a bio-inert HPLC system through the migration and modernization of a compendial SEC method outlined in the United States Pharmacopeia (USP) General Chapter <129>.
-
Achieving Licensing For A Healthcare Solution
6/16/2025
Facing strict regulations and tricky powders, a healthcare client sought an advanced filling solution. Learn how an expert collaboration led to licensed product, boosting precision and productivity.
-
Leveraging A Modern HPLC System For Peptide Drug Substances Analysis
8/22/2024
This study assesses a modern HPLC system within a routine QC testing environment focused on peptide-size biopharmaceuticals.
-
Improved GLP-1 Receptor Agonist Peptide Recovery
6/30/2025
Discover how an innovative technology enhances LC-MS analysis of GLP-1 receptor agonists by minimizing peptide loss and improving assay sensitivity and consistency.
-
Experience The Future Of Bioseparations
4/16/2024
Learn about an HPLC System designed to improve outcomes in QC labs with ease of use and simplicity at its core.
-
Mobile Lab For A Large Pharma Client
6/19/2024
Completed in 2021, learn how this custom BSL-3 mobile laboratory received PHAC approval and ensured a secure environment for PPD powder-related MTech development work.
-
Tackling Residual DNA Testing In Biotherapy Manufacturing
7/16/2025
Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.
-
Essential Insights Into Pharmaceutical Product Release: Part 2
1/13/2025
Optimizing pharmaceutical product release requires effective planning, specification development, electronic systems, and collaboration with CMOs, ensuring compliance, efficiency, and quality in the drug manufacturing process.
-
HPLC Autosampler Performance I: Challenging USP Methods
9/16/2024
In this study, the injection precision of an Alliance iS HPLC System was evaluated using four compendial HPLC methods from the USP with challenging method conditions and strict system suitability criteria.
-
A New Framework For Identifying Nitrosamine Risks And Derisking Products
6/18/2024
Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.